News | October 29, 2007

NIH Awards Penn $2.1M for Cardiovascular Disease Management Study

October 30, 2007 – The National Institutes of Health (NIH) has awarded cardiac researchers at the University of Pennsylvania a $2.1 million grant to pioneer studies in cardiovascular disease management and participate in a novel collaboration network to develop and implement research in this critically important field.
Penn is one of eight centers throughout the United States and Canada to be a named a Clinical Coordinating Center in the National Heart Lung and Blood Institute (NHLBI)-funded Clinical Research Network. This network will fund the creation of research and clinical trials that will answer questions in cardiothoracic surgery that have eluded researchers thus far.

The eight institutions that comprise the Cardiothoracic Surgical Network will collaborate over a five-year period to improve current technologies and create new ones to treat cardiovascular disease. “The establishment of this network will result in great benefit for patients. It also encourages leaders in cardiovascular surgery to share ideas, information, data and results,” said Michael Acker, M.D., chief of Cardiovascular Surgery at the Hospital of the University of Pennsylvania, and principal investigator for the grant.

“By enhancing the ability of research teams to evaluate new techniques, technologies and devices, the network promises to improve the scientific basis of care in cardiovascular disease,” said Elizabeth G. Nabel, M.D., director of the National Heart, Lung and Blood Institute of the National Institutes of Health.

The Penn researchers will propose protocols and participate in protocol development; screen and recruit cardiac surgery for up to five randomized clinical studies in cardiac surgery; develop strategies to encourage referrals from other specialty areas; draft publications and distribute research findings; and collaborate with other centers.

The seven other heart centers participating in this landmark NIH study are: the Cleveland Clinic, Columbia University, Duke Medical Center, Emory University, Montefiore-Einstein Heart Center, University of Virginia and the Montreal Heart Institute.

For more information:

Related Content

Medtronic Announces Global Resolute Onyx DES One-Month DAPT Study
News | Antiplatelet and Anticoagulation Therapies| August 18, 2017
Medtronic plc announced a global randomized clinical trial that will evaluate one-month dual antiplatelet therapy (DAPT...
Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
ESC 2017 late breaking trial hot line study presentations.
News | Clinical Study| August 16, 2017
Aug. 16, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking Clinic
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Abbott Initiates First Clinical Trial of Clip-Based Tricuspid Repair System
News | Heart Valve Technology| August 09, 2017
Abbott announced that the first patient has been enrolled in a clinical study to evaluate a minimally invasive clip-...
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Registry Identifies Early Onset of Heart Failure and Lack of Defibrillators in Asia
News | Heart Failure| August 03, 2017
August 3, 2017 — The Asian Pacific Society of Cardiology (ASPC) held its first-ever late-breaking...
Overlay Init